Search

Rheumatology Opportunity in Casper, WY making $375k Base Salary

PublishedPublished: 6/14/2022
Healthcare

Job Description

Job DescriptionRheumatology Opportunity making $375k Base Salary
Douglas, Casper, or Cheyenne, Wyoming

Opportunity Highlights

  • $325,000$375,000 Salary
  • 100% Outpatient Rheumatology
  • No Call
  • Approximately 2025 patients per day
  • MondayFriday, 8:00 AM5:00 PM
  • No inpatient rounding
  • New Rheumatology service line with opportunity to help shape and grow the program
  • Practice across multiple locations, with the ability to be based in Douglas, Casper, or Cheyenne
  • Established employed medical group with approximately 75 physicians/providers
  • Dedicated clinical support including MA or nursing support
  • On-site laboratory services at most locations
  • X-ray available at most locations
  • Infusion capabilities available in Casper and Douglas
  • Opportunity to utilize APP support as the service line develops
  • EMR: MEDITECH


Clinical Practice
Required clinical skills include:

  • Tissue biopsy
  • Microscopic specimen evaluation
  • Joint/soft tissue injections
  • Bone mineral density studies
  • Familiarity with IV therapies

Preferred skills include:

  • Arthroscopy
  • Management of vascular access devices/central venous catheters
  • EMG
  • NCV


Candidate Requirements

  • Board Certified or Board Eligible in Rheumatology


Benefits
Full benefits package includes:

  • Medical insurance
  • Dental insurance
  • Vision insurance
  • 457(b)
  • 401(a)
  • Life insurance
  • Additional comprehensive employee benefits


Infusion Resources
The organization has established infusion capabilities that can support Rheumatology care:

  • Douglas:at the hospitalty with up to 12 chairs

Physician-Friendly Wyoming Lifestyle with easy access to Casper and Denver
Interested in learning more? Contact us today to discuss the opportunity, Stephen.kanfer@optigygroup.com 954.263.5115

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...